metally.net

Metal News


Home > News > Findings from Two Phase 3 Studies of Janssen's Simeprevir...

Findings from Two Phase 3 Studies of Janssen's Simeprevir...



Print Back Archive

In both studies, 50 percent of patients receiving pegylated interferon and ribavirin alone achieved SVR12.




Click Here to read the entire article...


Music News Archive

Copyright 2005 Metally.net | Privacy Policy | Contact Us | Site Map | Search